Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2001Blood

Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions

View Full Paper
Ask AI
Bookmark
Share

Population

Chinese hamster ovary cells expressing recombinant GP Ibalpha and platelets

Design

Preclinical

Authors

JDJing‐fei DongYarsi UniversityMBMichael C. BerndtGeneral / Preventive / LipidsASAlicia J. SchadeBaylor College of Medicine

Discussion

Loading...

Member takes

Overview

Does not support clinical translation of anti-vWF antibodies; leaves open their role in human shear-dependent thrombosis.

Key Points

  • To determine whether ristocetin- or botrocetin-induced binding of von Willebrand factor to platelet glycoprotein Ibα more accurately models shear-stress-dependent interactions.
  • Screened a panel of anti-von Willebrand factor (vWF) and anti-GP Ibα antibodies with known effects on ristocetin- and botrocetin-dependent binding.
  • Measured antibody inhibition of Chinese hamster ovary cells expressing recombinant GP Ibα adhering to surface-immobilized vWF under hydrodynamic flow.
  • Evaluated the capacity of the antibodies to block shear-stress-induced platelet aggregation.
  • Shear-dependent interactions between vWF and GP Ibα correlated strongly with ristocetin-dependent, rather than botrocetin-dependent, binding under static conditions.
  • Specific anti-vWF monoclonal antibodies selectively inhibited shear-dependent platelet aggregation.

Structured PICO

P
Population
Chinese hamster ovary cells expressing recombinant GP Ibalpha and platelets
I
Intervention
Panel of anti-vWF and anti-GP Ibalpha antibodies
O
Outcome
Inhibition of adhesion of Chinese hamster ovary cells to surface-associated vWF under hydrodynamic flow or shear-stress-induced platelet aggregationsurrogate

This preclinical study demonstrates that shear-dependent vWF-platelet interactions correlate with ristocetin-dependent binding, providing mechanistic insights into thrombosis and potential therapeutic targets.

Cite This Study

Dong et al. (2001) studied this question.

synapsesocial.com/papers/6a8a882ee0083a7c2c437e6ehttps://doi.org/10.1182/blood.v97.1.162
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin1992 · 107 citations
  2. 2Expression of Platelet Glycoprotein (GP) V in Heterologous Cells and Evidence for Its Association with GP Ibα in Forming a GP Ib-IX-V Complex on the Cell Surface1995 · 142 citations
  3. 3Increased platelet sensitivity to ristocetin is predicted by the binding characteristics of a GPIb/IX determinant1990 · 22 citations
  4. 4Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib.1991 · 132 citations
  5. 5Von Willebrand Disease: A Database of Point Mutations, Insertions, and Deletions1993 · 215 citations